V 526Alternative Names: MRKAd5+6 Trigene; V526
Latest Information Update: 30 Dec 2014
At a glance
- Originator Merck & Co
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 15 Feb 2007 Phase-II clinical trials in HIV infections in USA (IM)